For the quarter ending 2025-09-30, DTIL made $13K in revenue. -$21,772K in net income. Net profit margin of -167476.92%.
| Income Statement | 2025-09-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenue | 13 | 29 | 22,707 | 576 |
| Research and development | 13,352 | 13,588 | 15,492 | 13,084 |
| General and administrative | 7,328 | 8,553 | 8,844 | 8,767 |
| Total operating expenses | 20,680 | 22,141 | 24,336 | 21,851 |
| Operating loss | -20,667 | -22,112 | -1,629 | -21,275 |
| Interest expense | - | 354 | 509 | 256 |
| Gain on change in fair value of warrant liability | - | - | 8,654 | 3,647 |
| (loss) gain from equity method investment | -591 | 1,342 | -70 | -875 |
| (loss) gain on changes in other fair value adjustments | -3 | 49 | -104 | 571 |
| (loss) gain on change in fair value of warrant liability | -1,179 | -804 | - | - |
| Interest expense | 362 | - | - | - |
| Interest income | 1,027 | 1,323 | 1,667 | 1,763 |
| Gain (loss) on disposal of assets | 3 | -9 | -109 | - |
| Total other (expense) income | -1,105 | 1,547 | 9,493 | 4,850 |
| (loss) income from operations | -21,772 | -20,565 | 7,864 | -16,425 |
| Net (loss) income | - | -20,565 | 7,864 | -16,425 |
| Basic (in shares) | 11,818,145 | 9,292,066 | -151,397 | 7,287,173 |
| Basic (in usd per shares) | -1.84 | -2.21 | 1.1 | -2.25 |
| Diluted (in shares) | 11,818,145 | 9,292,066 | -134,420.667 | 7,287,173 |
| Diluted (in usd per shares) | -1.84 | -2.21 | 1.097 | -2.25 |
PRECISION BIOSCIENCES INC (DTIL)
PRECISION BIOSCIENCES INC (DTIL)